Skip to content

   Pharma Publications

Neuropsychopharmacology
  • GLP-1 receptor agonist exenatide uncouples food intake from hedonic and anticipatory regulation in non-human primates: insights from an operant meal schedule paradigm
    Published on 2024-09-04
    1 year ago
  • Therapeutic efficacy of the BKCa channel opener chlorzoxazone in a mouse model of Fragile X syndrome
    Published on 2024-09-02
    1 year ago
  • Kappa opioid receptor availability predicts severity of anhedonia in schizophrenia
    Published on 2024-08-31
    1 year ago
  • Replicability and generalizability in population psychiatric neuroimaging
    Published on 2024-08-30
    1 year ago
  • What can neuroimaging of neuromodulation reveal about the basis of circuit therapies for psychiatry?
    Published on 2024-08-28
    1 year ago
  • Acute sleep disruption reduces fear memories in male and female mice
    Published on 2024-08-28
    1 year ago
  • Prevalence and correlates of irritability among U.S. adults
    Published on 2024-08-24
    1 year ago
« Previous 1 … 44 45 46 47 48 … 143 Next »
Journal of Psychopharmacology
  • Improving Translational Relevance in Preclinical Psychopharmacology (iTRIPP)
    Published on 2023-07-31
    2 years ago
  • Associations between regular cannabis use and brain resting-state functional connectivity in adolescents and adults
    Published on 2023-07-29
    2 years ago
  • Hippocampal phase precession is preserved under ketamine, but the range of precession across a theta cycle is reduced
    Published on 2023-07-29
    2 years ago
  • Postpartum psychosis: A proposed treatment algorithm
    Published on 2023-07-29
    2 years ago
  • Association of cannabis use with neurocognition in adolescents with bipolar disorder
    Published on 2023-07-27
    2 years ago
  • Ketamine-induced changes in resting state connectivity, 2 h after the drug administration in patients with remitted depression
    Published on 2023-07-26
    2 years ago
  • Pentoxifylline as adjunctive therapy in cognitive deficits and symptoms of schizophrenia: A randomized double-blind placebo-controlled clinical trial
    Published on 2023-07-19
    2 years ago
« Previous 1 … 44 45 46 47 48 … 134 Next »
European Neuropsychopharmacology
  • Controversies about ADHD: Early or also late-onset? Neurodevelopmental or also stress-related?
    Published on 2023-09-01
    2 years ago
  • The polygenic basis of relapse after a first episode of schizophrenia
    Published on 2023-08-20
    2 years ago
  • Biological markers of sex-based differences in major depressive disorder and in antidepressant response
    Published on 2023-08-17
    2 years ago
  • Effects of cannabis use on antidepressant treatment response to repetitive transcranial magnetic stimulation and ketamine
    Published on 2023-08-14
    2 years ago
  • Exploring the link between functional connectivity of ventral tegmental area and physical fitness in schizophrenia and healthy controls
    Published on 2023-08-09
    2 years ago
  • Psilocybin-assisted therapy for depression: A systematic review and dose-response meta-analysis of human studies
    Published on 2023-08-08
    2 years ago
  • Clozapine dosing patterns and clinical outcomes in patients with treatment resistant schizophrenia
    Published on 2023-08-07
    2 years ago
« Previous 1 … 44 45 46 47 48 … 153 Next »

   Pharma Pub